Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenoBank.io is a private genomics and healthcare technology company that combines DNA sample collection, genomic data management, and blockchain-based consent and provenance tools. The company markets privacy-preserving DNA kits and a patient-controlled data infrastructure that lets individuals store, manage, and license genomic and biosample-derived data through products such as GenoVault, BioNFT, and BioIP. Its platform appears to target both consumers and research or healthcare users with APIs, genomic analysis workflows, and data-governance tooling for secure sharing of biodata. GenoBank.io emphasizes patient ownership of genomic information, cryptographic chain of custody, programmable licensing, and compliance-oriented infrastructure rather than development of traditional therapeutics. The company also publishes technical whitepapers describing extensions into AI-enabled clinical-genomic analysis and synthetic biology data governance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenoBank.io.